Tryp Therapeutics closes the second tranche of its recently announced private placement for gross proceeds of CAD$3 million. Units are priced at CAD$0.15.
Tryp Therapeutics closes the second tranche of its recently announced private placement for gross proceeds of CAD$3 million. Units are priced at CAD$0.15.
Cybin announces a new clinical partner as it prepares for its Phase 1/2a clinical trial for CYB003.
Revitalist Lifestyle and Wellness announces 14th consecutive month of revenues growth and projects further growth across its network of 9 clinics.
Delic Holdings announces receiving a Health Canada 56 Research Exemption to conduct research on various psychedelic drugs.
Mydecine Innovations Group announces a share consolidation of 1 post-consolidation share for every 50 pre-consolidation shares.
Awakn Life Sciences reports that it now has three clinics in operation, including its new flagship clinic in London.
Red Light Holland to sponsor a "microdosing concert" in The Netherlands, given by mezza-soprano Helena van Heel.
Numinus Wellness is acquiring Novamind Inc in an all-share deal valued at CAD$26.2 million, creating an industry leader in research AND treatment.
Red Light Holland announces the purchase of 100 acres of farmland in Ontario that it is targeting for mushroom cultivation.
Revitalist announces a CAD$6 million private placement of convertible notes and warrants. Notes can be converted into common shares at a price of CAD$0.15.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now